Abstract
Purpose
To determine the epidemiologic and clinical characteristics of patients with malignant eyelid tumors in Hong Kong.
Methods
A computerized retrieval system was used to identify all patients with histologically confirmed malignant eyelid tumors residing in Western Kowloon and the Southern New Territories, Hong Kong, during the 13-year period from 1997 to 2009. The patients’ medical records were reviewed for clinical and demographic data.
Results
A total of 36 patients were identified; all were Chinese. The mean age at diagnosis was 73.4 ± 11.5 years. Women were more commonly affected. Each patient had 1 tumor. Tumors developed more commonly on the lower eyelid (n = 19; 52.8%) than on the upper eyelid (n = 11; 30.6%). The right eye was more often involved (n = 20; 55.6%). With regard to the type of tumor, 27 were basal cell carcinoma (BCC) (75%), 4 sebaceous gland carcinoma (11.1%), 2 squamous cell carcinoma (5.6%), 1 mucinous eccrine carcinoma (2.8%), 1 verrucous carcinoma (2.8%), and 1 metastatic carcinoma (2.8%). Most were treated by frozen section-guided excision and eyelid reconstruction. Recurrence occurred in 1 case only. Incidence was low until approximately 45 years of age, after which it rose sharply. The incidence continued to increase until above the age of 85 years. There was an overall increase in incidence from 0.6 per million in 1997 to 2.3 per million in 2009.
Conclusion
Increasing incidence of malignant eyelid tumors was noticed in Hong Kong from 1997 to 2009, with BCC dominating the incidence trend. Recurrence after complete surgical excision was uncommon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106:746–50.
Kaldor J, Shugg D, Young B, Dwyer T, Wang YG. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer. 1993;53:886–91.
Cheng SY, Luk NM, Chong LY. Special features of nonmelanoma skin cancer in Hong Kong Chinese patients: 10-year retrospective study. Hong Kong Med J. 2001;7:22–8.
Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678–83.
Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968–97. Br J Dermatol. 2003;148:1161–6.
Stang A, Stabenow R, Eisinger B, Jockel KH. Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. Eur J Cancer. 2003;39:1610–8.
de Vries E, Louwman M, Bastiaens M, de Gruijl F, Coebergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol. 2004;123:634–8.
Lin HY, Cheng CY, Hsu WM, Kao WH, Chou P. Incidence of eyelid cancers in Taiwan: a 21-year review. Ophthalmology. 2006;113:2101–7.
Hou PK, Tsai YS. Eyelid tumor: a statistical study. Acta Soc Ophthalmol Sin. 1977;16:34–6.
Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982;22:23–61.
Abe M, Ohnishi Y, Hara Y, Shinoda Y, Jingu K. Malignant tumor of the eyelid: clinical survey during 22-year period. Jpn J Ophthalmol. 1983;27:175–84.
Swanson MW, Cloud G. A retrospective analysis of primary eye cancer at the University of Alabama 1958–1988. Part 2: eyelid tumors. J Am Optom Assoc. 1991;62:820–3.
Sihota R, Tandon K, Betharia SM, Arora R. Malignant eyelid tumors in an Indian population. Arch Ophthalmol. 1996;114:108–9.
Lee SB, Saw SM, Au Eong KG, Saw SM, Chan TK, Lee HP. Incidence of eyelid cancers in Singapore from 1968 to 1995. Br J Ophthalmol. 1999;83:595–7.
Wang JK, Liao SL, Jou JR, Lai PC, Kao SC, Hou PK, et al. Malignant eyelid tumors in Taiwan. Eye. 2003;17:216–20.
Paavilainen V, Tuominen J, Pukkala E, Saari KM. Basal cell carcinoma of the eyelid in Finland during 1953–97. Acta Ophthalmol Scand. 2005;83:215–20.
Roh KK, Lee JH, Youn DH. Clinical analysis of tumors of the eye and its adnexa. Korean J Ophthalmol. 1988;2:27–31.
Takamura H, Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata University Hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol. 2005;49:349–54.
Francis IC, Benecke PS, Kappagoda MB. A ten-year hospital survey of eyelid cancer. Aust J Ophthalmol. 1984;12:121–7.
McCarthy W, Shaw H. Skin cancer in Australia. Med J Aust. 1989;150:469–70.
Fears T, Scotto J, Schneiderman M. Skin cancer, melanoma and sunlight. Am J Public Health. 1976;66:461–4.
Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER. Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States. J Am Acad Dermatol. 1993;29:184–9.
Pieh S, Kuchar A, Novak P, Kunstfeld R, Nagel G, Steinkogler FJ. Long term results after surgical basal cell carcinoma excision in the eyelid region. Br J Ophthalmol. 1999;83:85–8.
Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33:477–90.
Masuda T, Hayashi A, Watanabe M, Ueno H. Clinicopathological analysis of malignant eyelid tumors in Kochi Medical School. Nihon Ganka Kiyo (Folia Ophthalmol Jpn). 1993;44:1352–6.
Schottenfeld D. Basal-cell carcinoma of the skin: a harbinger of cutaneous and noncutaneous multiple primary cancer. Ann Intern Med. 1996;125:852–4.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mak, S.T., Wong, A.CM., Io, I.YF. et al. Malignant eyelid tumors in Hong Kong 1997–2009. Jpn J Ophthalmol 55, 681–685 (2011). https://doi.org/10.1007/s10384-011-0077-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-011-0077-4